RSS Feed Link

eMed Blog

Medtech predictions for 2014

2014 will be a better year for venture capital than 2013, but that won't necessarily mean it will be easier for entrepreneurs to raise money. And the life science IPO boom likely won’t be sustained.

on December 30, 2013
Category:  Creation  Ideation 
Advice from a former biotech exec and current VC

Frazier Healthcare’s newest venture partner is approaching her new gig with the smarts of a scientist, the gusto of an entrepreneur and the wisdom of a CEO who has both exited and shut down a company.

on December 23, 2013
Category:  Execution  Creation 
Complexities for startups within different healthcare spaces

"Domain specificity is important." It is so refreshing to hear a tech entrepreneur like Steve Blank say this. Blank has been working with researchers and clinicians for almost three years to bring the lean startup philosophy to healthcare. This is one of his conclusions about the industry.

on December 4, 2013
Category:  Creation  Execution  Growth  Ideation 
What you should know before your first fundraising pitch

At a Life Science Ventures Summit hosted by the Kauffman Foundation, Huffington Post writer Jennifer Hill led a discussion focused on the players in entrepreneurship and asked the panel about approaching investors (0:38:28 - 0:44:00). The panel included Nick Franano, Avi Roop and Geoff Clapp.

on November 27, 2013
Category:  Creation 
CEO stresses importance of lean budget and strong management for funding

Venture capital is highly competitive in the medical devices industry. Some VCs are even moving out of the device and healthcare space. But, in many cases, venture capital really still is the best kind of equity investment to be had in the medical device industry. If you have a high-risk, PMA-route device, a true innovation, it can be hard to round up the money to fund the device from its beginnings through FDA approval.

on November 25, 2013
Category:  Creation 
What to look for in digital health investors to get the right match

Halle Tecco, co-founder and CEO of Rock Health, led a digital health funding panel at a recent Life Science Ventures Summit hosted by the Kauffman Foundation. The panel included Dana Mead, Milena Adamian, Esther Dyson and Sean Ahrens.

on November 21, 2013
Category:  Creation 
Why a CEO should be critical of investors

With so much pressure on entrepreneurs to put together the right management team, create the perfect pitch and get all of the company's ducks in a row before going to look for an investment, it's easy to overlook the fact that a CEO should be just as critical of investors when deciding whether an investment opportunity is a good one.

on November 20, 2013
Category:  Creation 
Venture Capital: Dead or Alive in the 21st Century?

Is venture capital still viable as a model for funding new bioscience research, products and businesses?

on November 15, 2013
Category:  Creation  Growth  Execution 
What is holding your therapeutics pitch back?

Douglas Crawford of QB3 moderated a therapeutics funding panel at a recent Life Science Ventures Summit hosted by the Kauffman Foundation. Crawford focused a majority of the discussion on pitch strategies with Allan May, Karl Handelsman and Jesus Soriano

on November 7, 2013
Category:  Creation  Execution 
The first step to get funded

A Life Science Ventures Summit hosted by the Kauffman Foundation provided advice on funding strategies for diagnostic startups (0:42:17-0:48:05). Diana Kander of Kander Rigby led a panel with Una Ryan, Tito Serafini, Risa Stack, Zen Chu and Jill Carroll.

on October 17, 2013
Category:  Creation